Fig 2.

Representative results of secondary screening assays. (A) Dose-response data for amiodarone (AMD) showing relative light units of released AK activity at the indicated doses relative to those in DMSO (1%) (mock)-treated wells. (B) Percentages of cells staining with propidium iodide relative to DMSO-treated cells, as determined by fluorescence microscopy, for cells treated with amiodarone (AMD), trifluoperazine (TFP), and thioridazine (THZ) at the indicated drug concentrations (n, >100 cells).